- Specialization
- Speech
- Business
- Software Applications
- Market
- Healthcare
- Ecosystem
- Applications
- Customers
Enterprisesand 1 more customers valuesLess
- Small Businesses
More details
- Organization type
- Commercial Company
- Ecosystem
- Applications
- Business
- Software Applications
- Specialization
- Speech
- Market
- Healthcare
- Customers
- Enterprises, Small Businesses
- Delivery models
- Open Source, Hosted Software, On Premise Software
- Revenue models
- Subscription, Licensing
- Listing status
- Not classified
- Latest equity round
- Pre Seed
- Reported funding amount
- Not classified
About
Voquill builds an AI-native operating system and voice-reporting software for medical laboratories and pathologists. Its tools listen as clinicians work, draft finished sign-out reports, route findings into the correct fields, and can suggest billing codes; its key differentiators are style learning, real-time agentic workflows, open-source code, and local or private deployment options.
Market
Voquill operates across digital pathology/laboratory informatics and enterprise voice-productivity software: its medical-lab platform is intended to modernize workflows such as accessioning, reporting, coding, compliance, and revenue, while its flagship scribe converts spoken case descriptions into structured, sign-out-ready pathology reports. It differentiates from traditional LIS vendors and cloud-only dictation tools through pathology-specific agentic field placement, compatibility with existing LIS/IMS systems, an open-source core, and local or on-premises processing that keeps audio within the customer’s environment.
Voquill primarily targets pathology departments, pathology groups, and medical laboratories—especially teams whose pathologists need to produce reports faster and whose existing LIS/IMS workflow should remain in place. Its enterprise buyer profile includes lab leadership, IT administrators, CTOs, and security/compliance teams at organizations that require on-premises, private-cloud, or data-sovereign deployment.
At a Glance
Problem
Pathologists spend much of their working day examining tissues, cells, and fluids through a microscope and then documenting what they find. The reporting work is repetitive and tedious, while the specialty is already short-staffed: Voquill says pathologists generate $30–40 billion in annual billing, with roughly one-third of that spend going to documentation rather than diagnosis.
The killer use case is real-time case reporting during microscopic examination. Instead of interrupting diagnostic work to type or edit a transcript, a pathologist can describe the case aloud while scanning. Voquill targets the resulting capacity constraint by reducing case-writing time, allowing physicians to focus more on patient outcomes and sign out more cases.
Product / Service
Voquill is an AI coworker and pathology-reporting system that listens as a pathologist works, drafts a finished report, learns the physician’s phrasing and preferences from prior cases, and places findings into the appropriate fields, such as specimen, microscopic description, interpretation, and comments. It is designed to sit on top of existing laboratory information systems, imaging systems, templates, and snippets, avoiding a wholesale workflow migration.
The service goes beyond conventional speech-to-text: it aims to produce a sign-out-ready report rather than a raw transcript, with push-to-talk controls and medical-grade field placement. Voquill also markets a broader open-source dictation layer that works across desktop applications, can run locally or offline, supports bring-your-own API keys or cloud processing, and cleans up filler words, hesitations, and false starts. This gives customers a choice between privacy-oriented local deployment and cloud-based functionality, with enterprise options including on-premise deployment and custom integrations.
Market
Voquill operates primarily in AI-enabled pathology reporting and the broader market for medical-laboratory operating systems, with an adjacent position in AI voice-dictation software. Its larger ambition is an agentic operating system covering lab accessioning, workflow, reporting, coding, compliance, and revenue. In pathology reporting, Voicebrook is a clear incumbent competitor: its VoiceOver PRO product combines speech recognition, structured templates, CAP compliance, and LIS integration. In general-purpose AI dictation, Voquill is positioned as an open-source alternative to products such as Wispr Flow.
The company is an early-stage, YC-backed startup founded in 2026 and listed as active. Its YC launch materials report that it onboarded more than 25 pathologists in four weeks, including 25 pathologists at a leading F500 lab, with each saving about 20% of daily case-writing time. Public materials establish live usage and customer validation but do not disclose revenue, so Voquill is best characterized as having early commercial traction rather than being definitively classified as pre-revenue.
Founders & Leadership
Funding History
Y Combinator
Recent News
Voquill was identified as an EWC 2026 partner. The partnership positions Voquill as a pathology-reporting solution that turns voice into a polished, signed-off report in real time.
Voquill presented its realtime pathology scribe, which drafts reports, routes findings into the right fields, and learns a user's style. The product page says it works with any LIS or IMS.
Funblocks reviewed Voquill as an open-source alternative to voice-transcription tools, specifically comparing it with WisprFlow.
Voquill launched or received Product Hunt coverage as an open-source alternative to WisprFlow. The listing described voice typing across Windows, macOS, and Linux.
Active Roles
0No active roles right now.
Get notified when they postBusiness Model
Voquill uses a freemium model for individuals: its Personal plan is free, while Pro is listed at $8 per month when billed annually ($96 per year). It also sells custom enterprise solutions and commercial licenses supporting managed-cloud, self-hosted, and on-premise deployments.